UVXY News 53.92 05/02/2014 06:26:46 Ultra VIX Short-Term Fut

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra VIX Short-Term Fut ETF Proshares (UVXY) 53.92 $UVXY

Time to Tread Carefully in This Stock Market
at The Street - Thu May 01, 4:25PM CDT
The DJIA and the S&P 500 remain in overbought territory. The Nasdaq is close behind, with the Russell 2000 far behind and weak.

Temper Dow Growth Optimism on Volume Concerns
at The Street - Wed Apr 30, 5:40PM CDT
The Dow closed at a new 2014 high, but with lack of buying volume, traders and investors need to be cautious.

The Market's Winning Streak Ends
at The Street - Wed Apr 23, 4:17PM CDT
The winning streak for the Nasdaq, Russell 2000, and the S&P 500 ended on Wednesday at six days in a row. Volume was pathetic once again, which is a very bad sign.

S&P, Nasdaq, Russell on 6-Day Win Streak
at The Street - Tue Apr 22, 4:22PM CDT
Volume, however, continues to be a major concern on the upside.

Carnage in the Nasdaq and Russell 2000 Indexes
at The Street - Mon Apr 07, 4:12PM CDT
The selling continued as both the Nasdaq and Russell 2000 have entered into Trend Bearish territory.

DJIA and S&P Finally Succumb to the Nasdaq and Russell 2000
at The Street - Fri Apr 04, 4:12PM CDT
The DJIA and S&P 500 finally see some serious selling pressure.

DJIA, S&P 500 Continue to Outperform Others
at The Street - Thu Apr 03, 4:48PM CDT
The DJIA and the S&P 500 continue to outperform the Nasdaq and Russell 2000 on a daily basis. This is not good news for the intermediate term.

Volatility ETFs Crash as Market Fears Drop - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 1:00PM CST
Thanks to declining worries about the market, volatility ETNs have lost all of their 2014 momentum.

Volatility ETFs Skyrocket on Broad Market Weakness - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Mon Feb 03, 9:00AM CST
Inside the incredible run in the volatility ETF market over the past ten days.

What This Indicator Is Saying About the S&P 500
Lee Samaha, The Motley Fool - Motley Fool - Mon Dec 30, 6:00PM CST
There is no such thing as a magic indicator that will tell you when to buy and sell the S&P 500 , and we Fools do not recommend timing the market. However, Foolish investors can use the following indicator to decide whether to be fearful of a...

The Two Month VIX Cycle
Chad Karnes - ETFG - Fri Nov 15, 7:37PM CST
Buying the VIX is a great way to hedge your portfolio, if you can get the timing right. Luckily, the VIX has provided us some excellent technical clues that we can combine with the uncertainty from Washington to come up with some great VIX trades.

Are VIX Traders Riding the Wrong Roller Coaster?
Ron DeLegge - ETFG - Thu Oct 24, 9:58PM CDT
We highlight the performance discrepancies between the VIX and VIX ETPs and why traders need to understand the difference.

Is a Fearless Stock Market Cause for Concern?
Chad Karnes - ETFG - Wed Aug 14, 7:38PM CDT
The VIX can often signal a peak in stock market prices. By flipping it, it will typically move up and down along with the market and can sometimes be easier to help identify major market turning points.

Volatility Is On My Mind - Analyst Blog
Nick Kalivas - Zacks Investment Research - Fri Aug 02, 3:45PM CDT
S&P 500 30 day historical volatility is getting low. It???s worth watching.

A Common Sense View for Investing in Stocks
Chad Karnes - ETFG - Tue Jun 18, 3:31PM CDT
A little common sense can go a long way. After a 4 year non-stop market rally, long-term investors really should take a step back and wonder if they are just chasing returns or actually making good purchase decisions.

Unemployment: Is Resilience an Illusion? - Analyst Blog
Abhijit Ghosh - Zacks Investment Research - Thu May 16, 12:58PM CDT
After sinking to a five-year low last week, jobless claims have now jumped to a seasonally adjusted level of 360,000.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 40

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Long March Reflections: Lesson of Adaptation Endures

Updated Category News Views 11

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Continue Reading
Firehawk Defense Secures $150M, Valuation Hits $1.4B

Updated Category News Views 36

Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...

Continue Reading
Vertiv's Explosive Q3 Growth: A 2026 Power Move

Updated Category News Views 30

Vertiv's Third Quarter Triumph Imagine a company blowing past expectations like a hot knife through butter—yeah, that's Vertiv for you in 2026. These guys didn’t just ride the wave; they created a tsunami in the digital infrastructure sector. Net sales ballooned by a staggering 61% compared to last year's same quarter, pulling in $4.313 billion. When you consider the...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 38

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 18

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Right College Fit Crucial for Graduation Rates

Updated Category News Views 60

Navigating College Choices: More Than Just a Hunch When it comes to picking the right college, a lot of folks think it's like shooting in the dark—it's more than just a blind dart throw at a life map. According to a new report from the College Board, aligning with the right academic institution isn't merely a nice-to-have deal; it fundamentally shifts the odds in favor...

Continue Reading
GeoComm and Rypplzz Team Up for 3D Mapping Breakthrough

Updated Category News Views 45

Cracking the Mystery of Multilevel Locations Let me tell you, when lives hang in the balance, every second counts. We've all seen the chaos when first responders are trying to pinpoint someone's location inside a building with more floors than a loaf of bread. Enter GeoComm and Rypplzz, the new superheroes in this story. These two companies have realized the opportunity...

Continue Reading
Probiotics in Animal Feed: Market Reaches $8.76B by 2031

Updated Category News Views 14

Let's cut straight to the chase: the probiotics in animal feed market is steaming ahead, set to grow from a respectable $5.82 billion in 2026 to a hearty $8.76 billion by 2031. We're talking about a solid CAGR of 8.5% here. Now that's the kind of growth trajectory that gets even the most jaded traders sitting up and taking notice. Big Numbers in Livestock Nutrition...

Continue Reading
JELD-WEN Kicks Off 2027 Senior Notes Exchange

Updated Category News Views 22

A Fresh Play: Swapping Old for New With a fresh brew in hand and the latest company maneuvers on the table, JELD-WEN's move to exchange its 4.875% Senior Notes due 2027 for new secured notes maturing in 2031 comes into focus. This ain't just some routine shuffling of papers. They're calling up eligible folks holding onto those old notes, saying, 'Why stick with the old...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Seamless Customer Experience: Insights from Info-Tech

Updated Category News Views 159

Transforming Customer Engagement with Omnichannel Strategies In an era where digital interactions dominate, businesses are increasingly feeling the strain of disjointed customer experiences. Despite investing heavily in digital tools, many organizations find themselves navigating a labyrinth of disconnected channels, leading to frustrating customer journeys. Info-Tech...

Continue Reading
Bulat Utemuratov Foundation Provides Housing for Families in Need

Updated Category News Views 170

Bulat Utemuratov Foundation Provides Housing for Families in Need The Bulat Utemuratov Foundation has recently made a significant commitment to providing housing for families in need by donating 500 apartments to the local government of Astana. This generous contribution, valued at an impressive 10.5 billion tenge, is part of the Foundation's broader charitable initiative...

Continue Reading
Discover the Journey of a $100 Investment in AbbVie Stock

Updated Category News Views 170

The Growth of AbbVie: A Decade of Investment AbbVie (NYSE: ABBV) has shown impressive performance in the stock market, consistently outpacing market averages. Over the last decade, AbbVie has delivered an average annual return of 15.43%, exceeding general market returns by 2.87%. With a market capitalization nearing $406.27 billion, AbbVie stands as a significant player...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 122

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Experience Romer's Premier Baby Gear at Strolleria Event

Updated Category News Views 207

Join Romer for an Exclusive In-Store Event Romer, recognized for its premium baby gear designed for families, is thrilled to invite expectant parents, families, media, and influencers to an exciting event. This occasion will take place at Strolleria, a revered destination for baby products, and showcases Romer's elegant and safe gear. Details of the Event The event will...

Continue Reading